Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.
Breast Neoplasms
/ diagnosis
Colorectal Neoplasms
/ diagnosis
Cross-Sectional Studies
Early Detection of Cancer
/ statistics & numerical data
Female
Guideline Adherence
/ statistics & numerical data
Humans
Lung Neoplasms
/ diagnosis
Practice Guidelines as Topic
Stroke
/ epidemiology
Survivors
/ statistics & numerical data
United States
/ epidemiology
Cancer
Malignancy
Neoplasm
Screening
Stroke
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
01
11
2021
revised:
23
12
2021
accepted:
25
12
2021
pubmed:
16
1
2022
medline:
8
3
2022
entrez:
15
1
2022
Statut:
ppublish
Résumé
Cancer can present as stroke. Several cancer types have established screening guidelines. We investigated adherence to guideline-recommended cancer screening in stroke survivors versus the general population. We performed a cross-sectional analysis using 2012-2018 data from the CDC's Behavioral Risk Factor Surveillance System (BRFSS) survey. BRFSS is a nationally-representative telephone survey of non-institutionalized Americans that collects data about health conditions and behaviors, including cancer screening. We defined guideline-recommended colorectal, lung, and breast cancer screening based on the U.S. Preventive Services Task Force recommendations. We used survey-specific methods to estimate up-to-date screening rates for those with and without prior stroke. We used logistic regression to estimate the odds of up-to-date screening in stroke survivors compared to those without history of stroke after adjustment for potential confounders. Among 1,018,440 respondents eligible for colorectal cancer screening, 66% were up-to-date. Among 6,880 respondents eligible for lung cancer screening, 16% were up-to-date. Among 548,434 women eligible for breast cancer screening, 78% were up-to-date. After adjustment for demographics and confounders, stroke survivors were more likely to have up-to-date colorectal cancer screening (OR, 1.10; 95% CI, 1.05-1.16), equally likely to undergo lung cancer screening (OR, 0.99; 95% CI, 0.62-1.59), and less likely to undergo breast cancer screening (OR, 0.87; 95% CI, 0.80-0.94). In a nationwide analysis, stroke survivors had similar suboptimal adherence to guideline-recommended cancer screening as the general population.
Identifiants
pubmed: 35032754
pii: S1052-3057(21)00702-3
doi: 10.1016/j.jstrokecerebrovasdis.2021.106297
pmc: PMC8852296
mid: NIHMS1768287
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106297Subventions
Organisme : NINDS NIH HHS
ID : K23 NS091395
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Hooman Kamel serves as co-PI for the NIH-funded ARCADIA trial which receives in-kind study drug from the BMS-Pfizer Alliance and in-kind study assays from Roche Diagnostics, serves as Deputy Editor for JAMA Neurology, serves as a steering committee member of Medtronic's Stroke AF trial (uncompensated), and serves on an endpoint adjudication committee for a trial of empagliflozin for Boehringer-Ingelheim. Neal Parikh has received personal fees for medicolegal consulting on stroke. Babak Navi has received personal fees for medicolegal consulting on stroke. The other authors have no disclosures.
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Eur J Cancer. 2005 Feb;41(3):423-9
pubmed: 15691643
Breast Cancer Res. 2017 Nov 22;19(1):118
pubmed: 29162146
Clin Lung Cancer. 2020 May;21(3):e206-e211
pubmed: 32001154
J Am Coll Cardiol. 2017 Aug 22;70(8):926-938
pubmed: 28818202
Biosci Rep. 2017 Dec 12;37(6):
pubmed: 29026008
Breast Cancer Res Treat. 2015 Oct;153(3):659-67
pubmed: 26386956
Cancer. 2005 Dec 15;104(12 Suppl):2940-7
pubmed: 16276538
Ann Intern Med. 2002 Jul 16;137(2):132-41
pubmed: 12118972
Cerebrovasc Dis Extra. 2015 Oct 13;5(3):107-13
pubmed: 26648966
Stroke. 2021 Mar;52(3):1121-1130
pubmed: 33504187
Ann Intern Med. 2014 Mar 4;160(5):330-8
pubmed: 24378917
Ann Neurol. 2015 Feb;77(2):291-300
pubmed: 25472885
Cerebrovasc Dis. 2014;37(4):256-62
pubmed: 24686404
PLoS One. 2015 Dec 28;10(12):e0145492
pubmed: 26709510
J Thromb Haemost. 2004 Jun;2(6):884-9
pubmed: 15140122
JAMA. 2008 Dec 17;300(23):2765-78
pubmed: 19088354
N Engl J Med. 2015 Aug 20;373(8):697-704
pubmed: 26095467
Eur J Neurol. 2017 Mar;24(3):503-508
pubmed: 28026909
Neurology. 2010 Feb 9;74(6):494-501
pubmed: 20142616
Med Princ Pract. 2013;22(1):4-11
pubmed: 22584792
Eur J Appl Physiol. 2013 May;113(5):1213-22
pubmed: 23160655
Eur J Cancer. 2012 Aug;48(12):1875-83
pubmed: 22296948
J Am Heart Assoc. 2015 Nov 20;4(11):
pubmed: 26588943
J Neurooncol. 2018 May;137(3):551-557
pubmed: 29313183
AJNR Am J Neuroradiol. 2016 Nov;37(11):2033-2036
pubmed: 27365322
Eur Neurol. 2010;64(3):140-4
pubmed: 20668384
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):207-213
pubmed: 30678433
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
N Engl J Med. 2010 Sep 23;363(13):1203-10
pubmed: 20860502
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
J Neurooncol. 2007 Dec;85(3):307-9
pubmed: 17611718
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2429-2436
pubmed: 30255696
JAMA. 2018 May 8;319(18):1901-1913
pubmed: 29801017
JAMA. 2016 Jun 21;315(23):2564-2575
pubmed: 27304597
Circulation. 2013 Oct 22;128(17):1869-77
pubmed: 24025594
J Womens Health (Larchmt). 2015 Aug;24(8):641-7
pubmed: 26263281
Arch Neurol. 2009 Sep;66(9):1174-5
pubmed: 19752313
Cerebrovasc Dis. 2018;45(1-2):42-47
pubmed: 29402826